This paper is in the following e-collection/theme issue:

Peer Reviews (255)

Published on in Vol 2, No 3 (2021): Jul-Sep

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/33499, first published .
Peer Review of “Early Experience With Neutralizing Monoclonal Antibody Therapy for COVID-19: Retrospective Cohort Survival Analysis and Descriptive Study”

Peer Review of “Early Experience With Neutralizing Monoclonal Antibody Therapy for COVID-19: Retrospective Cohort Survival Analysis and Descriptive Study”

Peer Review of “Early Experience With Neutralizing Monoclonal Antibody Therapy for COVID-19: Retrospective Cohort Survival Analysis and Descriptive Study”

Authors of this article:

Anonymous1
Article Authors Cited by (1) Tweetations (2) Metrics

Journals

  1. Jarrett M, Licht W, Bock K, Brown Z, Hirsch J, Coppa K, Brar R, Bello S, Nash I. Authors' Response to Peer Reviews of “Early Experience With Neutralizing Monoclonal Antibody Therapy for COVID-19: Retrospective Cohort Survival Analysis and Descriptive Study”. JMIRx Med 2021;2(3):e33496 View